You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Alkermes halts development of opioid-induced constipation drug

Alkermes PLC, a maker of drugs for addiction and mental illness, said it would end work on a medicine to treat constipation caused by opioids such as morphine after study results fell short of expectations.

The drug, ALKS 37, “did not satisfy our pre-specified criteria for advancing into phase 3 clinical trials,” said the Dublin-based company, which has a research facility in Cambridge.

Continue reading below

The medicine was “generally well tolerated” by 150 patients in a phase 2 trial and eased constipation “compared to baseline.” Alkermes may try to license the compound to another company.

Other drugs Alkermes is working on include compounds to treat schizophrenia and depression. Its US products include Vivitrol, a once-a-month injection to treat alcoholism, and Risperdal Consta, for schizophrenia.

Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.